Rosiglitazone suppresses human lung carcinoma cell growth through PPARγ-dependent and PPARγ-independent signal pathways
Year: 2006
Type: article
Source: Molecular Cancer Therapeutics
Authors: ShouWei Han, Jesse Roman
Institutions: Emory University, Atlanta VA Medical Center
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2136136285